Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Trk agonist drugs rescue noise-induced hidden hearing loss
Katharine A. Fernandez, … , Sharon G. Kujawa, Albert S.B. Edge
Katharine A. Fernandez, … , Sharon G. Kujawa, Albert S.B. Edge
Published December 29, 2020
Citation Information: JCI Insight. 2021;6(3):e142572. https://doi.org/10.1172/jci.insight.142572.
View: Text | PDF
Research Article Otology

Trk agonist drugs rescue noise-induced hidden hearing loss

  • Text
  • PDF
Abstract

TrkB agonist drugs are shown here to have a significant effect on the regeneration of afferent cochlear synapses after noise-induced synaptopathy. The effects were consistent with regeneration of cochlear synapses that we observed in vitro after synaptic loss due to kainic acid–induced glutamate toxicity and were elicited by administration of TrkB agonists, amitriptyline, and 7,8-dihydroxyflavone, directly into the cochlea via the posterior semicircular canal 48 hours after exposure to noise. Synaptic counts at the inner hair cell and wave 1 amplitudes in the auditory brainstem response (ABR) were partially restored 2 weeks after drug treatment. Effects of amitriptyline on wave 1 amplitude and afferent auditory synapse numbers in noise-exposed ears after systemic (as opposed to local) delivery were profound and long-lasting; synapses in the treated animals remained intact 1 year after the treatment. However, the effect of systemically delivered amitriptyline on synaptic rescue was dependent on dose and the time window of administration: it was only effective when given before noise exposure at the highest injected dose. The long-lasting effect and the efficacy of postexposure treatment indicate a potential broad application for the treatment of synaptopathy, which often goes undetected until well after the original damaging exposures.

Authors

Katharine A. Fernandez, Takahisa Watabe, Mingjie Tong, Xiankai Meng, Kohsuke Tani, Sharon G. Kujawa, Albert S.B. Edge

×

Figure 4

Systemic AT protection is dose responsive.

Options: View larger image (or click on image) Download as PowerPoint
Systemic AT protection is dose responsive.
(A and B) Amitriptyline in sa...
(A and B) Amitriptyline in saline (AT; 12.5, 25, or 50 mg/kg) or the saline vehicle alone was delivered once daily for 5–9 days. Animals were noise exposed on day 3, 6 hours after injection. DPOAE amplitudes recovered by 2 weeks, but ABR amplitudes did not (compare A and B). Compared with vehicle-only controls, a significant preservation of ABR wave 1 amplitude at 30 kHz (B) (F1, 392 = 70.39, P < 0.0001) is apparent in mice treated with 50 mg/kg AT. (C and D) Similarly, synapses (pictured in C and quantified in D) show significant protection by high-dose AT in the 30 kHz region relative to vehicle-only controls (F1, 116 = 18.90, P < 0.0001). Data are shown as mean ± SEM, n = 10–30/group). (A, B, and D) Results of 2-way ANOVA comparing vehicle-only controls and drug-treated animals, with Bonferroni multiple comparisons test; **P < 0.01, ***P < 0.001, ****P < 0.0001. Untreated mice (23) are shown for comparison.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts